Related Experiment Video
Updated: Jan 21, 2026

Cardiopulmonary Bypass in a Mouse Model: A Novel Approach
Published on: September 22, 2017
Calcium Administration During Weaning From Cardiopulmonary Bypass: A Narrative Literature Review
Vladimir V Lomivorotov1, Elizaveta A Leonova2, Alessandro Belletti3
1Department of Anaesthesiology and Intensive Care, E. Meshalkin National Medical Research Center, Novosibirsk, Russia; Novosibirsk State University, Novosibirsk, Russia.
Insights
Intravenous calcium may offer transient cardiovascular benefits during cardiopulmonary bypass weaning but carries risks. Further research is needed to determine its overall impact on patient outcomes.
Area of Science:
- Cardiology
- Critical Care Medicine
- Pharmacology
Background:
- Managing patients during weaning from cardiopulmonary bypass requires safe and effective strategies.
- Intravenous calcium is sometimes used as an initial treatment option.
- Calcium's physiological role suggests potential cardiovascular support during this critical phase.
Purpose of the Study:
- To evaluate the role and effects of intravenous calcium administration in patients undergoing weaning from cardiopulmonary bypass.
- To assess the potential benefits and risks associated with calcium use in this patient population.
Main Methods:
- Review of physiological roles of calcium in cardiovascular function.
- Analysis of reported transient effects of calcium administration.
- Consideration of potential adverse events and limitations.
Main Results:
- Mild hypocalcemia post-cardiopulmonary bypass does not significantly impair cardiovascular function.
- Calcium administration may transiently improve hemodynamic parameters like blood pressure and cardiac index.
- Potential adverse effects include reduced graft flow, blunted response to beta-agonists, and organ injury.
Conclusions:
- While calcium may offer short-term hemodynamic advantages, its impact on significant clinical outcomes remains unknown.
- Potential side effects may restrict the use of calcium salts.
- Further studies are essential to fully understand the effects of calcium on patient outcomes.
Abstract:
The search for safe and effective patient management strategies during weaning from cardiopulmonary bypass is ongoing; intravenous calcium is occasionally used as a first-line drug. The physiologic role of calcium suggests that it can support the function of the cardiovascular system during this critical period. Patients may be mildly hypocalcemic after cardiopulmonary bypass; however, this degree of hypocalcemia does not significantly impair the cardiovascular system. The transient beneficial effects of calcium administration (increase in arterial blood pressure, systemic vascular resistance, cardiac index, stroke volume, and coronary perfusion pressure) might be helpful in cases of moderate contractility reduction or vasoplegia. Nonetheless, effects on clinically relevant endpoints are unknown, and possible systemic side effects, such as transient reduction in internal mammary artery graft flow, attenuation of the effects of β-sympathomimetics, "stone heart" phenomenon, and pancreatic cellular injury, may limit the use of calcium salts. Further studies are needed to expand the understanding of the effects of calcium administration on patient outcomes.
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Cardiopulmonary Resuscitation I: Adult
Cardiopulmonary Resuscitation III: AED Use
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiopulmonary Resuscitation II: ACLS Airway Management

